Fuller & Thaler Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.8M | Sell |
|
|||||
|
2025
Q1 | $86.3M | Sell |
|
|||||
|
2024
Q4 | $89.2M | Sell |
|
|||||
|
2024
Q3 | $72.1M | Buy |
|
|||||
|
2024
Q2 | $53.7M | Buy |
|
|||||
|
2024
Q1 | $15.6M | Sell |
|
|||||
|
2023
Q4 | $36.6M | Buy |
|
|||||
|
2023
Q3 | $23.1M | Sell |
|
|||||
|
2023
Q2 | $27.2M | Sell |
|
|||||
|
2023
Q1 | $86.7M | Sell |
|
|||||
|
2022
Q4 | $84.8M | Buy |
|
|||||
|
2022
Q3 | $33.9M | Sell |
|
|||||
|
2022
Q2 | $43.2M | Sell |
|
|||||
|
2022
Q1 | $51.6M | Buy |
|
|||||
|
2021
Q4 | $47.2M | Buy |
|
|||||
|
2021
Q3 | $40.7M | Buy |
|
|||||
|
2021
Q2 | $20.5M | Buy |
|
|||||
|
2021
Q1 | $19.8M | Buy |
|
|||||
|
2020
Q4 | $18.5M | Buy |
|
|||||
|
2020
Q3 | $3.7M | Buy |
|
|||||
|
2020
Q2 | $3.67M | Sell |
|
|||||
|
2020
Q1 | $6.5M | Buy |
|
|||||
|
2019
Q4 | $8.42M | Buy |
|
|||||
|
2019
Q3 | $8.6M | Buy |
|
|||||
|
2019
Q2 | $6.24M | Buy |
|